Wird geladen...
Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
BACKGROUND: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the Covid-19 pandemic. Evaluation of Covid-19 vaccine efficacy against SARS-CoV-2 variants is urgently needed to inform vaccine development and use. METHODS: In thi...
Gespeichert in:
| Veröffentlicht in: | N Engl J Med |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Massachusetts Medical Society
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8091623/ https://ncbi.nlm.nih.gov/pubmed/33951374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2103055 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|